Objective: Although there are limited numerous reports of candidemia in adults, data on paediatrics are stil limeted. The aim of the present study was to compare the aetiology and risk factors of nosocomial candidemia among the paediatric and adults in our hospital.
Introduction
The incidence of the nosocomial fungal infections has increased over the past two decades. Candida spp. have become the fourth most common cause of nosocomial bloodstream infections [1] [2] [3] . During this period, the isolation rate of non-albicans Candida spp. has increased as well. The species distribution of Candida isolates varies between countries, regions and institutions [1, 4] . Several studies have determined the risk factors fungal infections. These risk factors include the length of stay in the intensive care unit, the use of intravascular catheters, malignancy, surgical operations, chemotherapy, antimicrobial agents and steroid use [2, [5] [6] [7] [8] [9] .
Although there have been numerous studies of candidemia in adults [2, [5] [6] [7] [8] ] data on pediatric populations [9] [10] [11] [12] are still limited. The aim of this study was to compare the etiology and risk factors of nosocomial candidemia among pediatric and adult patients at a university hospital in 2007-2009.
Materials and Methods

Study population
A retrospective study was performed between June 30, 2007 and June 30, 2009 in the 900-bed Ondokuz Mayis University Hospital. All pediatric and adult cases of nosocomial candidemia were included in this study. Nosocomial candidemia was defined as the presence of at least one blood culture positive for Candida obtained from a peripheral vein in a patient admitted for more than 72 h in association with temporally related signs and symptoms. Patients were considered pediatric if their age was less than 18 years old.
The following variables were studied: age, sex, and underlying diseases. The predisposing factors that we reviewed in the patients' data included the following: antimicrobial chemotherapy, parenteral nutrition, vascular catheterization, urinary catheters, endotracheal intubation, hemodialysis, tracheostomy, surgery, prolonged intensive care unit stay, and steroid therapy.
Microbiological procedures
Blood cultures were processed at a microbiology laboratory using an automated blood culture system (BacT/ALERT® 3D, bioMérieux, France). Passages on Sabouraud dextrose agar (SDA) (Merck, Darmstadt, Germany) were performed. After screening using the germ-tube test, yeast were identified according to their morphology on cornmeal Tween 80 agar, colony morphology and color on CHROMagar Candida (BBL, Becton Dickinson, Sparks, MD, USA) and biochemical tests using an API ID 32C yeast identification system (bioMéri-eux, Marcy l'Etoile, France). Only one isolate from each patient was included. Three reference strains (Candida albicans ATCC 26255, Candida krusei ATCC 6258, Candida parapsilosis ATCC 22019) were included in this study.
Statistical analysis
Descriptive statistics were used to summarize the data. Pearson's chi-square test and Fisher exact test were used to evaluate the association between qualitative variables, and the Mann-Whitney test was used for the comparison of quantitative variables. The two-tailed level of significance was 5%, and data analysis was performed with SPSS software. Survival rates were evaluated by Kaplan-Meier analysis and the long rank test.
Results
During the period of study, 120 patients had nosocomial candidemia in our hospital. There were 51 (42.5%) pediatric patients and 69 (57.5%) adult patients. Most of our pediatric patients were male (51.0%), and the median age was 1.0 year old (mean 3.86±4.737). Most of the adults with nosocomial candidemia were male (56.5%), and the median age was 54.0 years old (range, 19-83 years old).
Although non-albicans Candida species represented more than half (56.7%) of all candidemia cases, C. albicans was the most frequent etiological agent (43.3%) of candidemia in our hospital. The most common non-albicans species isolated was C. parapsilosis (25.0%), followed by C. tropicalis (17.5%). Fluconazole-resistant species, such as C. glabrata (5.0%) and C. krusei (3.3%), were isolated rarely in our patients. Table 1 shows the distribution of Candida species among the pediatric and adult patients with nosocomial candidemia. There was no statistically significant difference in the distribution of Candida species between pediatric and adult patients (p>0.05), but C. dubliniensis, C. guilliermondii and C. lusitaniae were isolated only in pediatric patients in our study. In addition, C. kefyr was isolated only from adults. Table 2 shows the major underlying diseases in pediatric and adult patients with nosocomial candidemia. The major underlying diseases observed in the pediatric patients were prematurity (25.5%), neoplasia (17.6%), and infection (15.7%). The major underlying diseases observed in the adults were neoplasia (36.2%), trauma (13.0%), and infection (17.4%). Table 3 shows the predisposing factors for the pediatric and adult cases with nosocomial candidemia, including the following: antimicrobial chemotherapy, parenteral nutrition, vascular catheterization, urinary catheter, endotracheal intubation, hemodialysis, tracheotomy, surgery, prolonged intensive care unit stay, and steroid therapy. There was no statistically significant difference in the predisposing factors between pediatric and adult patients with nosocomial candidemia (p>0.05). We also evaluated the relationship between the presence of predisposing factors and the etiological agent that was isolated. There was no statistically significant difference in the predisposing factors present between infections caused by C. albicans and those caused by non-albicans species.
When time-to-death estimates were evaluated with the Kaplan-Meier method and compared using the log-rank technique (Figure 1 ), no statistically significant difference between pediatric and adult patients with nosocomial candidemia was observed.
Discussion
Although non-albicans Candida species represented more than half of all candidemia cases, the present study determined that C. albicans is the most frequent etiological agent of candidemia in our hospital. This finding, together with data from other countries, confirms that C. albicans is still a leading cause of candidemia [1, 3, 6-8, 10, 11] . Nevertheless, the prevalence of C. albicans (43.3%) in this study was lower than that reported in Canada (59%), Europe (58%), and the USA (54%); however, this prevalence was similar to the prevalences in Korea (49%), Latin America (47%), Israel (44%), and Japan (41%) [1, 13] . In this study, C. parapsilosis was the most common non-albicans species identified, There was no statistically significant difference in predisposing factors between paediatric and adult with nosocomial candidemia (p>0.05) which is consistent with data from Japan, Canada, South America, and Korea [14] . Fluconazole-resistant species, such as C. glabrata and C. krusei, were rarely isolated from our patients. The comparison of Candida spp. between pediatric and adult patients revealed no significant difference, but C. dubliniensis, C. guilliermondii and C. lusitaniae were isolated only in pediatric patients in our study. In addition, C. kefyr was isolated only from adult patients. In some studies, C. parapsilosis had been found to be the main etiological agent in pediatric patients [9] , but in our study, C. parapsilosis was the second most common etiological agent after C. albicans.
In addition, C. parapsilosis has been found to be associated with the use of central venous catheters and total parenteral nutrition [5] . We did not find any difference in the prevalences of C. albicans and C. parapsilosis among risk factors such as the use of central venous catheters and total parenteral nutrition. Neoplasia was the main underlying disease in adults. The use of steroids and immunosuppressors in patients with neoplasia may be risk factors for candidemia. Prematurity was the most frequent underlying disease in pediatric patients; the reason for candidemia in premature infants may be the immaturity of the immune system in neonates and the use of broad-spectrum antibiotics to treat infections. Most of our patients had received broad-spectrum antimicrobials and total parenteral nutrition. In our study, the mortality rates were not different between the pediatric and adult patients. This finding differed from those of previous studies. Numerous studies [10, 11, 15, 16] have found lower mortality rates in pediatric patients than in adults. In a large, prospective study of candidemia, it was shown that the mortality rate due to candidemia caused by C. parapsilosis was usually lower than that of candidemia caused by other Candida species. This difference may play a role in the reported mortality differences [11] . In our study, the distribution of C. parapsilosis was not different between adults and children.
In conclusion, we reviewed data on the species distribution, underlying diseases and predisposing factors related to cases of nosocomial candidemia among pediatric and adult patients over a two-year period at a tertiary university hospital in Turkey. These data suggest that C. albicans is the most frequent etiological agent of candidemia in our hospital, although non-albicans Candida species represented more than half of all candidemia cases. The most common non-albicans species was C. parapsilosis in both adults and children in our hospital. There was no statistically significant difference in the distribution of Candida species between pediatric and adult patients. Neoplasia (in adults) and prematurity (in children) were the main underlying diseases. The predisposing factors and mortality rates were not different between the pediatric and adult patients. Our study was limited because the data were derived from a single institution, the design was retrospective, and there was no control group without candidemia. Further studies are needed to fully analyze the dynamics of candidemia.
